- riskScore quantifies a woman's risk of developing breast cancer by combining genetic markers throughout the genome with her family and clinical history.
Wednesday, September 6, 2017
Myriad Genetics (MYGN) launched riskScore
Myriad Genetics launched riskScore, a new clinically validated precision medicine tool to enhance its myRisk Hereditary Cancer test
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment